Trending News
News
News
Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
Vermillion obtains exclusive rights the development of biomarkers that can be applied toward disease detection, classification and monitoring of prevalent cancers.
News
DiscoveRx Corporation Signs Agreement with Cosmo Bio
DiscoveRx Corporation announces the selection of Cosmo Bio as a key distributor for the Japanese territory.
News
Select Biosciences Announces the Availability of Exhibition-only Passes for Screening, ADMET & MedChem Europe
The event will see over 350 people gathering to attend presentations on the latest on biomolecular screening, medicinal chemistry or ADME-toxicology advances.
News
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
Under the agreement, Takeda will receive exclusive rights to develop and commercialize select molecules in Japan.
News
Vyteris Announces Redirection of Business towards the Advancement of Peptide Delivery
Vyteris, with approval from its Board of Directors, has redirected its business to focus on the development of peptide delivery using its Smart Patch technology.
News
Archemix Earns Milestone Payment from Initiation of Phase 1 Clinical Trial by Nuvelo
The milestone payment has been triggered by Nuvelo’s enrollment of the first volunteer in a Phase 1 study of NU172, a thrombin-inhibiting aptamer.
News
Oncolytics Biotech Announces Publication of Research on Combination Reovirus and Radiation Therapy
Dr. Kevin Harrington at The Institute of Cancer Research published the results of their work testing combination treatment schedules of reovirus and radiation in human and murine tumor cells in vitro and in vivo.
News
SAFC Pharma Expands its Pharmorphix Solid State Chemistry Services
The Company announces the second-phase of a $600,000 expansion of its solid-state services Pharmorphix™ research facility in Cambridge, UK.
News
Therapeutics and Research in Oncology (TRIO) Registers with OneOncology
TRIO and its 50 plus member-practices in Maryland, Virginia and Washington, D.C. have registered with OneOncology to use its electronic negotiation platform.
News
Karo Bio and Zydus Cadila Sign Research Agreement for Development of Novel Drugs to Treat Inflammatory Diseases
Both companies initiate a three year research collaboration with the purpose to discover and develop selective glucocorticoid receptor.
Advertisement